#United States #Bridgewater #OmniActive #Ashwagandha #Zenroot

OmniActive Health Technologies Unveils Zenroot

OmniActive Health Technologies has made significant strides in the dietary supplement industry with its recent announcement regarding Zenroot, a uniquely formulated, root-only ashwagandha extract. This product, which features a low daily dosage of 125 mg, has officially received verification from the U.S. Pharmacopeia (USP) Ingredient Verification Program. This recognition is not just a stamp of approval; it underscores OmniActive's commitment to quality and transparency in the emerging market for herbal supplements.

The Significance of USP Verification

USP's verification serves as an independent quality assurance measure that many brands are currently seeking. As consumer demand grows for natural health solutions, the importance of procuring safe and well-tested ingredients cannot be overstated. Brijesh Shah, COO of OmniActive, emphasized that while the ashwagandha sector is expanding rapidly, there is an increasing necessity for high-quality products free from adulteration. He stated, "Brands are looking for botanical ingredients backed by independent quality assurance. With Zenroot, we are proud to offer a differentiated ashwagandha solution that delivers science, quality, and formulation flexibility."

This essential verification allows dietary supplement manufacturers to confidently integrate Zenroot into their products. Emily Rose Britton, PhD, Senior Manager of Market Development for Verification Programs at USP, highlighted the significance of OmniActive's achievement by saying, "This accomplishment demonstrates a commitment to quality, enabling dietary supplement manufacturers to identify OmniActive's Zenroot as a trusted quality ingredient."

Market Expansion and Consumer Trends

The ashwagandha market is projected to witness robust growth, with estimates suggesting an increase from $0.76 billion in 2025 to $1.18 billion by 2030. Notably, the market for gummies, functional foods, and beverages is set to outpace traditional supplements, pointing toward a changing landscape of consumer preferences. Products like Zenroot, which boast low-dose formulations and flexible applications, are becoming increasingly attractive to brands looking to innovate in this space.

Formulation Challenges and Solutions

Zenroot's profile makes it an ideal ingredient for a variety of applications, including capsules, tablets, gummies, and beverages. Its organoleptic properties allow brands to overcome common formulation challenges often encountered with ashwagandha. OmniActive's commitment extends beyond market relevance; the company is investing in ongoing scientific research to further validate Zenroot's benefits.

Two recently published clinical studies reveal that Zenroot shows superior bioavailability when compared to two leading ashwagandha extracts, even at a mere intake of 125 mg daily. These studies demonstrated that Zenroot can reduce occasional stress and feelings of anxiety, along with promoting better mood and sleep compared to a placebo group.

As consumers become more discerning about health products, the need for verified, quality ingredients grows. OmniActive recognizes that ensuring a quantifiable amount of bioactive compounds like withanolides is critical for achieving desired health outcomes.

Conclusion

OmniActive Health Technologies continues to lead the way in the natural dietary supplement sector with innovations like Zenroot, which are designed to meet both consumer needs and market demands for quality and transparency. For brands and manufacturers looking to enhance their product offerings, Zenroot represents a substantial advancement in the standardization and verification of ashwagandha extracts. To learn more about Zenroot and its capabilities, you can visit their official page at OmniActive's Zenroot.

As the market evolves, Zenroot stands as a beacon of quality and trust—a significant step forward in the journey toward improved health and wellness through natural solutions.